Applications Published 11 July 2001
Published: 8-Mar-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Preparation of aqueous clear solution dosage forms with bile acids
Yoo, Seo Hong 1113785*New pharmaceutical formulation
AstraZeneca 1113786*Transdermal devices comprising essential oils for aromatherapy
Lavipharm Laboratories 1113788*Method and compsn for treating inflammatory bowel disease
University of Florida 1113789*Compsn containing cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases
Korea Institute of Bioscience and Technology 1113790*Bioflavonoids as a blood glucose level lowering agent
Korea Institute of Science and Technology 1113791*A new compsn
AstraZeneca 1113792*Methods of treating viral disease
Vertex Pharmaceuticals 1113793*Tryptophenyl esters and their N-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes
Max-Planck-Gesellschaft zuer Foerderung der Wissenschaften 1113794*Fused pyridine inhibitors of CGMP phosphodiesterase
Bristol-Myers Squibb 1113795*Treatment of persistent pain
Eli Lilly 1113796*Topical formulation of alkyl-phenyl-pyrridone
Scheiwe, Max Werner 1113797*Protein formulations
Eli Lilly 1113799*Combinations of tetracyclic cyclic GMP-specific phosphodiesterase inhibitors with further therapeutic agents.
ICOS Corp 1113800*Method of treating atherosclerosis employing an AP2 inhibitor and combination
Bristol-Myers Squibb 1113801*Antiviral combinations of lamivudine and adefovir
Glaxo Group 1113802*Antiviral combinations comprising lamivudine and abacavir
Glaxo Group 1113803*Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
Akesis Pharmaceuticals 1113804*Inhibition of toxic materials or substances using dendrimers
Starpharma 1113805*Anionic or cationic dendrimer antimicrobial or antiparasitic compsns
Starpharma 1113806*Cell mediated gene delivery using muscle-derived cells for treating muscle- and bone-related injury or dysfunction
University of Pittburgh 1113807*A method of treatment and agents useful for same
University of Melbourne 1113808*Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
Merck Patent 1113809*Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
Board of Regents, the University of Texas System 1113810*Chemokine receptor antagonist and cyclosporin in combined therapy
Applied Research Systems 1113811*Method and compsns for preventing or reducing HIV infection by use of inhibitors for leucine aminopeptidase
Canbreal Therodiagnostics Canada 1113812*Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner
University of Maryland, Baltimore 1113813*Human chorionic gonadotrophin vaccines
Zonagen 1113814*Novel influenza vaccine virus compsn
Baxter 1113815*Process and materials for the rapid detection of Streptococcus pneumoniae employing purified antigen-specific antibodies
Binax 1113817*Methods of treating IGE-related disorders and compsns for use therein
Dynavax Technologies Corp 1113818*Expandable microparticle intracellular delivery system
Rothman, James 1113820*
